Stock HEAL PT MEDIKALOKA HERMINA TBK
Add to a list
To use this feature you must be a member
Log inSign up

Ratings PT Medikaloka Hermina Tbk

Equities

HEAL

ID1000143100

End-of-day quote INDONESIA S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
1,280 IDR -1.54% Intraday chart for PT Medikaloka Hermina Tbk -4.12% -14.09%
Apr. 26 PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 28 PT Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 31.46 times its estimated earnings per share for the ongoing year.
  • The company appears highly valued given the size of its balance sheet.
  • The company is not the most generous with respect to shareholders' compensation.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
PT MEDIKALOKA HERMINA TBK Stock PT Medikaloka Hermina Tbk
-14.09% 1.17B -
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+25.52% 88.99B
C+
CVS HEALTH CORPORATION Stock CVS Health Corporation
-24.52% 74.82B
B-
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+0.49% 25.03B
C+
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.31% 17.88B
A-
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-14.25% 16.43B
B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.97% 15.77B
A-
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.20% 13.21B
C+
NATERA, INC. Stock Natera, Inc.
+70.11% 13.08B
C-
DAVITA INC. Stock DaVita Inc.
+40.44% 12.9B
B-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. HEAL Stock
  4. Ratings PT Medikaloka Hermina Tbk